Stocktoria

Oric Pharmaceuticals, Inc. ORIC

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-04-24 · LEI

Oric Pharmaceuticals, Inc. statistics & valuation

Market cap$986.5M
P / B2.6×
Return on equity-33.7%
Return on capital-36.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2019202020212022202320242025
Operating margin (%)
2019202020212022202320242025
Return on equity (%)
-25.40% -28.80% -40.10% -44.90% -52.60% -33.70% 2019202020212022202320242025
Shares outstanding
2.0M 36.7M 39.4M 45.1M 54.9M 71.0M 98.5M 2019202020212022202320242025
Net debt ($)
-$215.5M 2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-28.60% -24.70% -26.40% -36.10% -40.00% -46.60% -31.70% 2019202020212022202320242025
Free cash flow margin (%)
2019202020212022202320242025
Debt / equity (×)
0.04× 2019202020212022202320242025
EPS ($)
-$2.07 -$2.25 -$1.96 -$1.83 -$1.47 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Return on assets-31.7%-46.6%-40.0%-36.1%-26.4%-24.7%-28.6%
Return on equity-33.7%-52.6%-44.9%-40.1%-28.8%-25.4%29.8%
Debt / equity————0.04×——
Current ratio14.1310.5610.3913.6815.8732.9616.81

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.